do glp-1 agonists have cardiovascular benefit Receptor in the Rehabilitation of Patients with Heart Failure: Mechanisms, Clinical Evidence, and Future Perspectives GLP-1 receptor agonists and myocardial
Description
Second, the gap between currently available alternatives (semaglutide at 15%) and tirzepatide (20-22%) may close significantly within the next 1-2 years as these newer options reach the market
Watson, K
Tirzepatide (Zepbound, Mounjaro) Tirzepatide is a first-in-class dual agonist
With GLP-1 agonists causing appetite loss, there is a risk for nutrient deficiencies
Multiple System Atrophy Is Associated With Changes in Peripheral Insulin-Like Growth Factor System
